ENDOCYTE, INC. SCHEDULE OF TERMS FOR CHANGE IN CONTROL AND SEVERANCE AGREEMENTS WITH EXECUTIVE OFFICERS March 2017
Exhibit 10.20
ENDOCYTE, INC.
SCHEDULE OF TERMS FOR
CHANGE IN CONTROL AND SEVERANCE AGREEMENTS
WITH EXECUTIVE OFFICERS
March 2017
|
|
| Termination without Cause or Resignation for Good Reason, prior to a Change in Control or after 12 months following a Change in Control | Termination without Cause or Resignation for Good Reason, within 12 months following a Change in Control | |||||
| Name of Executive Officer | Date of Agreement | Severance Payment – Percentage of Base Salary | 140% COBRA Continuation | Accelerated vesting for equity awards that would have vested over the following | Severance Payment – Percentage of Base Salary | Severance Payment – Percentage of Target Bonus | 140% COBRA Continuation | Percentage of unvested equity awards that will immediately vest |
| Michael A. Sherman | 6/17/16 | 100% | 12 months | 12 months | 200% | 200% | 24 months | 100% |
| Michael A. Andriole | 2/20/17 | 75% | 9 months | 9 months | 150% | 150% | 18 months | 100% |
| Alison A. Armour | 8/10/15 | 75% | 9 months | 9 months | 150% | 150% | 18 months | 100% |
| Beth A. Taylor | 5/15/15 | 75% | 9 months | 9 months | 100% | 100% | 12 months | 100% |
| Michael A. Brinkley | 5/15/15 | 75% | 9 months | 9 months | 100% | 100% | 12 months | 100% |
| Christopher P. Leamon | 5/15/15 | 75% | 9 months | 9 months | 150% | 150% | 18 months | 100% |
| Katherine K. Parker | 5/15/15 | 75% | 9 months | 9 months | 100% | 100% | 12 months | 100% |
